Skip to content

ARVIS TKA vs Conventional TKA

A Prospective Study Using Augmented Reality Versus Conventional Jig Controls in Total Knee Arthroplasty for Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06663384
Acronym
ARVIS
Enrollment
50
Registered
2024-10-29
Start date
2024-12-01
Completion date
2027-11-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

osteoarthritis of knee, Total Knee Replacement

Brief summary

This study is a pilot analysis of a novel augmented reality guidance platform, the augmented reality visualization and information system (ARVIS, Insight Medical), with aims to demonstrate accuracy of bone resection and implant alignment during kinematic alignment total knee arthroplasty.

Detailed description

This study is a Randomized Controlled Trial evaluating the effectiveness of an AR system utilized to perform bone cuts when compared to traditional jigs in primary TKA for treatment of primary osteoarthritis. Our primary objective is to determine if the ARVIS augmented reality platform is a reliable tool to restore native lower extremity alignment during TKA. An estimated 50 patients will be enrolled in the study, with 25 in the AR-group and 25 in the non-AR conventional kinematic alignment group. A 20% attrition rate (10 patients) is expected throughout the study, leaving 20 patients in each study group. The Investigator intend to evaluate only patients who've met the clinical and radiographic indications for TKA for one knee (Killgren Lawrence Grade \> III) and have less than Killgren Lawrence Grade II OA of the contralateral knee. The Investigators intend to use the uninvolved knee as a radiographic comparison to determine ARVIS's post-operative restorative accuracy to the patient's native alignment. Pre- and post-operative radiographs will include standing knee AP, PA, lateral, sunrise, and hip-to-ankle radiographs. The investigators have chosen to reproduce the patient's native alignment during TKA rather than mechanical alignment given the predominance of recent literature demonstrating superior function and outcome of kinematic based techniques. Intraoperatively, the investigators will use ARVIS to prospectively record bone resection thickness, distal femoral resection angle, femoral component sagittal orientation, femoral component rotation, tibial resection thickness, coronal tibial resection angle, and tibial slope. The ARVIS is an augmented reality headset with a heads-up display capable of presenting pre-resection hip center and lower extremity alignment. The heads-up display provides real time, intra-operative feedback during bone resections to optimize the component position and lower extremity alignment as compared to the uninvolved contralateral limb. Unlike other methods used to prepare bone cuts during TKA, such as traditional jigs or robotic systems, ARVIS is a self-contained, wearable surgical guidance device controlled by the surgeon, designed to ensure surgeon can focus on their patient while they perform bone cuts on tibia and femur - not a screen across the room. The procedure of TKA is the same for traditional approach utilizing jigs and ARVIS approach. ARVIS has received 510(k) clearance from the FDA as of July 2021.

Interventions

OTHEREvaluation of Augmented Reality technology in TKA compared to standard TKA

Evaluation of effectiveness of AR system used to perform bone cuts when compared to traditional jigs in primary TKA

Sponsors

Foundation for Orthopaedic Research and Education
Lead SponsorOTHER
DonJoy Orthopedics
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years old * Scheduled for primary conventional TKA with kinematic alignment * Primary Diagnosis of Osteoarthritis (Killgren Lawrence Grade \> III) on affected side * Able to provide informed consent

Exclusion criteria

1. Patients with a previous operation of the same knee, including ACL reconstruction, fracture fixation, previous arthroplasty. 2. Patients that had a conversion to a different procedure intraoperatively or shortly after the TKA. 3. Diagnosed with greater than Killgren Lawrence Grade II OA on the contralateral knee 4. Patients that did not complete the TKA. 5. Patients the Investigator deems not able to follow through with study requirements such as follow-up visits or PROM's.

Design outcomes

Primary

MeasureTime frameDescription
Radiographic Measurements bilateral kneesFrom enrollment until 1 year follow-up visit.Weight bearing anterposterior (AP), lateral and sunrise views of both knees to measure tibial slope, hip-knee alignment, medial proximal tibial angle, mechanical lateral distal femoral angle, joint line convergence angle, anatomic- mechanical angle.

Secondary

MeasureTime frameDescription
PROMIS-10 Surveyfrome enrollment until 12 month final study visitPatient Reported Outcome Measure Information System with 10 questions about subjects pain and function.
Knee Society Score (KSS)From enrollment until final visit at 12 months after surgeryA simple and objective scoring system to rate the knee and patient's functional abilities before and after total knee arthroplasty.
Knee Injury and Osteoarthritis outcome Score (KOOS)from enrollment until completion of study at 12 months post surgeryKOOS is a 42-item questionnaire that assesses the patient's opinion about the health, symptoms, and functionality of their knee.
Numeric Pain Rating Score (NPRS)From enrollment until final study visit at 12 months post surgery1-10 numeric scale that asks patients to rate their pain in the last 24 hours.

Countries

United States

Contacts

CONTACTDebbi Warren, RN
dwarren@foreonline.org813-910-3688
CONTACTPeter Simon
psimon@foreonline.org312-509-5761
PRINCIPAL_INVESTIGATORBrian Palumbo, MD

Florida Orthopaedic Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026